EPA and DHA Fatty Acids Induce a Remodeling of Tumor Vasculature and Potentiate Docetaxel Activity
Open accessThe DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Abstract
n-3 long chain Polyunsaturated Fatty Acids (n-3 LCPUFA) have been shown to improve the efficacy of conventional chemotherapies used for breast cancer treatment. In addition to their reported ability to increase the chemosensitivity of cancer cells, we hypothesized that n-3 LCPUFA could induce a remodeling of the vascular network in mammary tumors. A contrast-enhanced ultrasound method was used to monitor the vascular architecture during docetaxel treatment of mammary tumors in rats fed either a control or an n-3 LCPUFA-enriched diet (docosahexaenoic acid (DHA)/eicosapentaenoic acid (EPA)). The vascular network was remodeled in favor of smaller vessels (microvascularization), which represented 54% of the vasculature in n-3 LCPUFA tumors but only 26% in control tumors after 2 weeks of chemotherapy. Importantly, vascularization changes occurred both before and during docetaxel treatment. The density of smaller vessels quantified before chemotherapy was correlated with improved tumor size reduction by docetaxel treatment. Furthermore, transcript levels of the angiogenesis-specific genes epiregulin and amphiregulin were reduced by ~4.5- and twofold in tumors obtained from rats fed an n-3 LCPUFA-enriched diet compared to those of rats fed a control diet, respectively. Their expression levels were negatively correlated with tumor regression after chemotherapy. Taken together, this preclinical data strengthen the potential usefulness of n-3 LCPUFA as a complementary clinical strategy to improve drug efficiency via remodeling of the tumor vasculature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“EPA and DHA also have antitumoral and anticancer properties.”
From Microalgae n-3 PUFAs Production and Use in Food and Feed Industries (2021) · cites this paper as [57]
In the citing paper
“Indeed, EPA and DHA can improve drug delivery by modifying the tumor vasculature with architectural remodeling [57], and present antiangiogenic activities [58,59].”
From Microalgae n-3 PUFAs Production and Use in Food and Feed Industries (2021) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 2×
“Vessels become smaller in diameter, less tortuous and are more efficient at delivering oxygen, nutrients, and drugs [2,3].”
BackgroundMolecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529 · cited 1×
“Unlike what is observed in a normal vascular network, tumor vessels have been described as vasodilated and hyperpermeable [13,14].”
BackgroundHigh Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222 · cited 1×
“These alterations can lead to increased interstitial fluid pressure and prevent adequate drug delivery [2,15].”
BackgroundPrinciples and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675 · cited 1×
“During vessel normalization, the architecture of the vasculature is largely restored, in a process that reduces the diameter of microvessels and prunes the most immature vasculature [21].”
BackgroundTong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189 · cited 3×
“Vessels become smaller in diameter, less tortuous and are more efficient at delivering oxygen, nutrients, and drugs [2,3].”
BackgroundKinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170 · cited 1×
“This effect creates a window of opportunity during which various concomitantly administered therapies are likely to be most effective [22,23].”
BackgroundCellular abnormalities of blood vessels as targets in cancer
Baluk, P., Hashizume, H., & McDonald, D. M. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.005 · Cited by 781 · cited 1×
“Unlike what is observed in a normal vascular network, tumor vessels have been described as vasodilated and hyperpermeable [13,14].”
BackgroundTumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization
Fukumura, D., & Jain, R. K. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.05.003 · Cited by 691 · cited 2×
“This type of vasculature allows the efficient delivery of cytotoxic agents into tumors and enhances chemotherapy efficacy [1,3].”
BackgroundConnor, K. M., SanGiovanni, J. P., Lofqvist, C., Aderman, C. M., Chen, J., Higuchi, A., Hong, S., Pravda, E. A., Majchrzak, S., Carper, D., et al. (2007) · Nature Medicine · doi:10.1038/nm1591 · Cited by 688
Polyunsaturated fatty acids and inflammation
Calder, P. C. (2006) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.05.012 · Cited by 638
Cited by
Microalgae n-3 PUFAs Production and Use in Food and Feed Industries
Remize, M., Brunel, Y., Silva, J. L., Berthon, J.-Y., & Filaire, E. (2021) · Marine Drugs · doi:10.3390/md19020113 · Cited by 214
“Indeed, EPA and DHA can improve drug delivery by modifying the tumor vasculature with architectural remodeling [57], and present antiangiogenic activities [58,59].”
BackgroundNutraceuticals in the Mediterranean Diet: Potential Avenues for Breast Cancer Treatment
Augimeri, G., Montalto, F. I., Giordano, C., Barone, I., Lanzino, M., Catalano, S., Andò, S., Amicis, F. D., & Bonofiglio, D. (2021) · Nutrients · doi:10.3390/nu13082557 · Cited by 63
“Specifically, EPA and DHA potentiate docetaxel activity in remodeling tumor vasculature of mammary tumors [180], opening a window of opportunity in the clinical strategy for breast cancer patients.”
BackgroundConte, C., Longobardi, G., Barbieri, A., Palma, G., Luciano, A., Poggetto, G. D., Avitabile, C., Pecoraro, A., Russo, A., Russo, G., et al. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122618 · Cited by 35
Theinel, M. H., Nucci, M. P., Alves, A. H., Dias, O. F. M., Mamani, J. B., Garrigós, M. M., Oliveira, F. A., Rego, G. N. A., Valle, N. M. E., Cianciarullo, G., et al. (2023) · Nutrients · doi:10.3390/nu15061310 · Cited by 42
“[48] 2020 Induction by drug NMU drug Rats Sprague-Dawley Wildtype F 6 Torres-Adorno et al.”
BackgroundMethodInfluentialFodil, M., Blanckaert, V. D., Ulmann, L., Mimouni, V., & Chénais, B. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19137936 · Cited by 28
“In addition, in a similar model of a chemically-induced mammary tumor, DHA was shown to induce a microvascularization before and during docetaxel treatment, suggesting the potential usefulness of n-3 LC-PUFAs as an adjuvant strategy to enhance common anticancer drug efficiency [62].”
BackgroundOmega-3 fatty acids: molecular weapons against chemoresistance in breast cancer
Marchio, V., Augimeri, G., Morelli, C., Vivacqua, A., Giordano, C., Catalano, S., Sisci, D., Barone, I., & Bonofiglio, D. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00694-x · Cited by 27
“Furthermore, it was observed that ω-3 PUFA supplementation can induce vascular remodeling in tumors from rats bearing chemically induced breast cancer before and during docetaxel treat-ment [137].”
Liu, J., Zhang, N., Wu, J., Dong, P., Lv, H., Wang, Q., Wang, S., Yang, H., Wang, S., Li, X., et al. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s379758 · Cited by 12
“OH of the DTX.”
BackgroundInfluentialDong, P., Lv, H., Jia, W., Liu, J., Wang, S., Li, X., Hu, J., Zhao, L., & Shi, Y. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2152133 · Cited by 12
“DHA also increases the sensitivity of cancer cells to antitumor drugs such as DTX and paclitaxel (Chauvin et al., 2016; Song & Kim, 2016; Corsetto et al., 2017; Goupille et al., 2020; Newell et al., 2022).”
BackgroundDong, P., Liu, J., Lv, H., Wu, J., Zhang, N., Wang, S., Li, X., Hu, J., Wang, A., Li, D. J., et al. (2022) · Biomaterials Science · doi:10.1039/d2bm00337f · Cited by 10
Wang, S., Liu, J., Lv, H., Huang, X., Dong, P., Wang, Q., Yang, H., Wang, S., Li, X., Hu, J., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114567 · Cited by 9
Li, Z., Cai, H., Zheng, J., Chen, X., Liu, G., Lv, Y., Ye, H., & Cai, G. (2023) · Aging · doi:10.18632/aging.205081 · Cited by 8
“Studies have shown that AREG can promote multiple cancer models in the invasion and in regulating tumorigenesis [60, 61] and that targeted stromal-derived AREG can eliminate the AREG generated by stromal and cancer cells at the TME ecological site [50] and can be used in combination with anti-PD-1 antibodies [62].”
[Research advances in the effect of long-chain polyunsaturated fatty acids on neonates].
Yang, Q., & Lin, X.-Z. (2021) · PubMed Central · doi:10.7499/j.issn.1008-8830.2104087 · Cited by 4
Lv, H., Jia, W., Dong, P., Liu, J., Wang, S., Li, X., Hu, J., Zhao, L., & Shi, Y. (2023) · Current Drug Delivery · doi:10.2174/1567201820666230622105503 · Cited by 3
Rojas-Solé, C., Torres-Herrera, B., Gelerstein-Claro, S., Medina-Pérez, D., Gómez-Venegas, H., Alzolay-Sepúlveda, J., Chichiarelli, S., Saso, L., & Rodrigo, R. (2024) · Applied Sciences · doi:10.3390/app14114548 · Cited by 3
Az ómega-3 zsírsavak jelentősége a nem alkoholos zsírmájbetegség kezelésében
Makó, R. A., Egresi, A., Blázovics, A., Oszlányi, R., & Hagymási, K. (2023) · Orvosi Hetilap · doi:10.1556/650.2023.32834 · Cited by 2
Mebami, J. N., Ufuan, A. A., Fotsing, I. S., Mbape, S. S., Djikeng, F. T., & Zingue, S. (2026) · Food biomacromolecules. · doi:10.1002/fob2.70065
Guo, G., Huang, X., & Xiufang, W. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118377
Metadata
- Authors
- Goupille, C., Vibet, S., Frank, P. G., & Mahéo, K.
- Affiliations
- Université de Tours (FR)
- Corresponding author
- Mahéo, Karine
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-07-14
- Volume
- 21
- Issue
- 14
- Pages
- 4965
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7404030
- OpenAlex
- W3042508855
- Cited by
- 17
- References
- 45
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 5 · 2022: 5 · 2021: 3
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Ligue Contre le Cancer
- Université François-Rabelais
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- n-3 long-chain polyunsaturated fatty acids, docosahexaenoic acid, eicosapentaenoic acid, docetaxel, breast cancer, microvascularization, contrast-enhanced ultrasound, epiregulin, amphiregulin, angiogenesis, chemosensitization, dietary fatty acids
- MeSH terms
- Docetaxel, Animals, Diet, Docosahexaenoic Acids, Fatty Acids, Female, Neovascularization, Pathologic, Eicosapentaenoic Acid, Fatty Acids, Omega-3, Mammary Neoplasms, Animal, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.